VBI Vaccines Inc (VBIV)
0.6045
-0.02
(-2.50%)
USD |
NASDAQ |
Apr 17, 16:00
0.5635
-0.04
(-6.78%)
Pre-Market: 08:29
VBI Vaccines Cash from Financing (TTM): 22.70M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 22.70M |
September 30, 2023 | 22.43M |
June 30, 2023 | 19.44M |
March 31, 2023 | 19.44M |
December 31, 2022 | 19.45M |
September 30, 2022 | 22.34M |
June 30, 2022 | 9.959M |
March 31, 2022 | 22.68M |
December 31, 2021 | 44.29M |
September 30, 2021 | 56.93M |
June 30, 2021 | 99.16M |
March 31, 2021 | 144.62M |
December 31, 2020 | 122.39M |
September 30, 2020 | 106.79M |
June 30, 2020 | 94.99M |
March 31, 2020 | 36.82M |
December 31, 2019 | 37.42M |
September 30, 2019 | 81.05M |
June 30, 2019 | 43.55M |
March 31, 2019 | 43.61M |
December 31, 2018 | 43.62M |
September 30, 2018 | 67.29M |
June 30, 2018 | 67.29M |
March 31, 2018 | 67.23M |
December 31, 2017 | 67.24M |
Date | Value |
---|---|
September 30, 2017 | 23.26M |
June 30, 2017 | 23.04M |
March 31, 2017 | 36.50M |
December 31, 2016 | 36.48M |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | 5.550M |
March 31, 2015 | 5.564M |
December 31, 2014 | 6.077M |
September 30, 2014 | 0.0448M |
June 30, 2014 | 0.0469M |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.0065M |
September 30, 2013 | 0.0062M |
June 30, 2013 | 0.0344M |
March 31, 2013 | 0.0344M |
December 31, 2012 | 1.928M |
September 30, 2012 | 2.835M |
June 30, 2012 | 0.0313M |
March 31, 2012 | 52.77M |
December 31, 2011 | 52.69M |
September 30, 2011 | 53.97M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
9.959M
Minimum
Jun 2022
144.62M
Maximum
Mar 2021
54.02M
Average
37.42M
Median
Dec 2019
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Ampio Pharmaceuticals Inc | 0.00 |